NCT06752278

Efficacy of Pilocarpine As a Secretagogue Versus Artificial Tears for the Treatment of Dry Eye

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Al-Azhar University · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Management approaches for dry eye disease (DED) typically start with low-risk, easily accessible, patient-applied therapies like artificial tears for early-stage disease. As the condition worsens, treatment progresses to more advanced therapies for severe forms of DED. This study aims to compare the effectiveness and safety of pilocarpine as a secretagogue versus artificial tears in the treatment of dry eye disease. Our goal is to provide reliable, high-quality evidence regarding the efficacy of secretagogues, thereby contributing to the development of recommendations that aid clinicians in their decision-making process

Conditions

• Dry Eye Disease (DED)

Interventions

Type	Name	Description
DRUG	Pilocarpine	Pilocarpine is a muscarinic agonist
DRUG	artificial tears	artificial tears used for the treatment of Dry eye

Timeline

• Start date: 2024-10-01
• Primary completion: 2024-12-01
• Completion: 2024-12-20
• First posted: 2024-12-30
• Last updated: 2024-12-30

Locations

1 site across 1 country: Egypt